We used a health economics model to evaluate the cost effectiveness in Spain of a recently licensed recombinant quadrivalent influenza vaccine (QIVr), which... J Ruiz-Aragón,S Márquez-Peláez - 《Vaccines》 被引量: 0发表: 2023年 Cost-utility analysis of influenza vaccination in a population ...
Influenza vaccine cost effective in Korean ACS patientsNo Abstract available for this article.doi:10.1007/s40274-017-3958-zNoneSpringer International PublishingPharmacoeconomics & Outcomes News
Mercer NJ. Cost analysis of public health influenza vaccine clinics in Ontario. Can J Public Health 2009;100(5):340-43.Mercer NJ. Cost analysis of public health influenza vaccine clinics in Ontario. Can J Public Health. 2009;100(5):340-3....
Now in the Russian Federation it is registered, in addition to TIV, quadrivalent vaccine (QIV) manufactured in the Russian Federation and including antigens of influenza B viruses of the two lineages. The purpose of work was assessment of the cost-effectiveness of QIV in comparison with TIV ...
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics. 2001 Aug;108:...doi:10.1136/EBM.7.2.63B. SchwartzBMJ Publishing Group LtdEvidence Based MedicineSchwartz B. An intranasal influenza vaccine for the prevention of influenza ...
A letter to the editor is presented in response to the article "Four year efficacy of prophylactic human papillomavirus (HPV) quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial," in the July 20, 2010 issue....
Something else to keep in mind is the age of the dog. Weimaraner puppies will often cost you hundreds of dollars more than even one just a couple of years old. It also is important to mention thatmale Weimaranerstend to be more expensive than females. ...
MF59-adjuvanted trivalent influenza vaccine;aTIV;high-dose trivalent influenza vaccine;TIV-HD;MF59-adjuvanted quadrivalent influenza vaccine;aQIV;cost-effectiveness;relative vaccine efficacy;rVE;cost saving 1. Introduction Individuals aged 65 years and above are at increased risk of complications and death...
MF59-adjuvanted quadrivalent influenza vaccine (aQIV) for use in adults ≥ 65 years in Ireland. Methods: A published dynamic influenza model incorporating social contact, population immunity, and epidemiological data was used to assess the cost-effectiveness of aQIV in adults ≥ 65 years of age ...
‘中国卫生经济' 第28卷第10期( 总第320期) 2009年10月老年人群流感疫苗接种的效果评价及成本效益分析彭亚光①,王全意②,时福礼①摘要:流行性感冒( 简称流感1是常见的全球性传染病。每年全球约有300～500万人口因感染而导致流感样疾因流感致死的人数也在25万一50万之间。特别是老年人群患流感后容易出现严重...